Pitfalls, Perils and Pearls: Identifying and Managing Gynecologic Treatment Toxicity
The introduction of novel therapies for gynecologic malignancies such as immunotherapy, SBRT and complex brachytherapy can lead to increased frequency of severe toxicities for which treatment options may be limited.
Category
- Brachytherapy
- Gynecologic
- Immunotherapy
- SBRT
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
How Sentinel Lymph Node Biopsy is Impacting Adjuvant Radiation Treatment in Gynecologic Cancers
There is increasing use of sentinel lymph node biopsy in gynecologic cancers but how best to integrate this information into post-operative radiation treatment recommendations is not always clear. This includes how to interpret isolated tumor cells, micrometastasis, and macrometastasis.
Category
- Gynecologic
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
2026 ASTRO Annual Business Meeting (Virtual)
Hear ASTRO Leadership provide a summary year in review and strategic planning for the year ahead!
Category
- General RO
- Health Policy/Informatics
Format
- Sessions onDemand
Credits
Cost $0.00
Designing, Implementing and Interpreting Patient Reported Outcomes in Clinical Investigation
Patient reported outcomes (PROs) are a key component of evaluating cancer therapy. For clinical trialists, the proper design, implementation and evaluation of patient reported outcomes is critical for designing studies that will impact and inform daily practice.
Category
- Professional Development
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
Radiation Therapy for Nonmalignant Conditions: Challenges and Updates
This educational series explores the evolving role of radiation therapy in managing nonmalignant conditions, addressing current challenges, emerging evidence, and specialized applications in clinical practice. Topics Covered
Category
- Central Nervous System
- Functional/Nonmalignant RT
Format
- Sessions onDemand
Credits
- 3.00 AMA PRA Category 1 Credit™
- 3.00 Certificate of Attendance
Cost $299.00
Palliative Radiation Therapy for Spine Metastases
This presentation focuses on the management of spine metastases with palliative radiation, emphasizing a multidisciplinary and patient-centered approach incorporating up-to-date clinical practice guidelines and evidence.
Category
- Central Nervous System
- Palliative Care
- Hypofractionation
Format
- Sessions onDemand
Credits
- 0.75 AMA PRA Category 1 Credit™
- 0.75 Certificate of Attendance
Cost $149.00
Radiation for Non-Spine Bone Metastases
This presentation reviews the role of radiation therapy in the management of non-spine bone metastases, focusing on patient evaluation, treatment intent, dose selection, and integration with systemic and surgical care.
Category
- SBRT
- Sarcoma
- Palliative Care
Format
- Sessions onDemand
Credits
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Certificate of Attendance
Cost $149.00
Palliative Radiation for Head & Neck and Cutaneous Malignancies
This session provides an overview about palliative radiation for head and neck and skin malignancies. It focuses on a brief review of the available evidence supporting palliative radiation therapy for these diseases and help participants identify resources to help guide them in application.
Category
- Skin
- Head and Neck
- Palliative Care
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
Hypofractionation for Soft Tissue Sarcoma
Modern trends throughout radiation oncology have favored short-course hypofractionated regimens which are frequently more cost-effective and convenient for patients. Over the past two years, multiple prospective studies have emerged supporting hypofractionation in soft tissue sarcoma.
Category
- Sarcoma
- Hypofractionation
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
Relevant or Relegated? Radiotherapy for Stage III NSCLC in the Neoadjuvant Era
There are many ongoing advances in the multidisciplinary management of stage III NSCLC, in particular the advent of neoadjuvant immunotherapy in patients who are resectable.
Category
- Thoracic
- Immunotherapy
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00

Facebook
X
LinkedIn
Forward